Barbara Bastow

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)

Babafemi Taiwo, Lu Zheng, Sébastien Gallien et al. · AIDS · 2011 · 147 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Timothy Wilkin, Huichao Chen, Michelle Cespedes et al. · Clinical Infectious Diseases · 2018 · 139 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics

Marlene Smurzynski, Ann C. Collier, Susan L. Koletar et al. · HIV Clinical Trials · 2008 · 89 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

No Evidence for Decay of the Latent Reservoir in HIV‐1–Infected Patients Receiving Intensive Enfuvirtide‐Containing Antiretroviral Therapy

Rajesh T. Gandhi, Ronald J. Bosch, Evgenia Aga et al. · The Journal of Infectious Diseases · 2009 · 69 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)

Cecilia M. Shikuma, Yang Yang, Marshall J. Glesby et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17